Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Zong Li Zhang"'
Autor:
Li-xin Du, Guo-li Sheng, An-da Shi, Kang-shuai Li, Zeng-li Liu, Yong-chang Tang, Yi Liu, Zong-li Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundHepatocellular carcinoma (HCC) is the most common primary liver cancer and often arises in the context of chronic liver disease, such as hepatitis B or C infection, and cirrhosis. Advanced unresectable HCC (uHCC) presents significant treatm
Externí odkaz:
https://doaj.org/article/44d0ce7a80324cce8cd1a87c32cde748
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundOur study aimed to develop a nomogram incorporating cytokeratin fragment antigen 21–1 (CYFRA21–1) to assist in differentiating between patients with intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC).MethodsA total
Externí odkaz:
https://doaj.org/article/b22f161f94ac48cf862ee232afa5b289
Autor:
Jian-Hua Chang, Bo-Wen Xu, Di Shen, Wei Zhao, Yue Wang, Jia-liang Liu, Guang-Xiao Meng, Guang-Zhen Li, Zong-Li Zhang
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Its invasiveness and ability to metastasize contributes to an extremely high patient mortality. However, the molecular mechanisms that underlie the characteristics o
Externí odkaz:
https://doaj.org/article/0de1984f1f4d48bb999df717fff07967
Autor:
Li-ming Zhao, An-da Shi, Yan Yang, Zeng-li Liu, Xiao-Qiang Hu, Li-Zhuang Shu, Yong-chang Tang, Zong-li Zhang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Cholangiocarcinoma (CCA) is a highly malignant tumor of the hepatobiliary system that has failed to respond to many traditional therapies to a certain extent, including surgery, chemotherapy and radiotherapy. In recent years, the new therapeutic sche
Externí odkaz:
https://doaj.org/article/2a0c10de9b42439c967a9e077d8a17d1
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundHepatocellular carcinoma (HCC) is a well-described complication of Budd-Chiari syndrome (BCS). However, the risk factors of BCS in developing HCC and clinical characteristics and imaging features of BCS-associated HCC is still to be determi
Externí odkaz:
https://doaj.org/article/a778be2a2f0d4e61affb81259cad8397
Autor:
Yun-cheng Li, Kang-shuai Li, Zeng-li Liu, Yong-chang Tang, Xiao-Qiang Hu, Xing-yong Li, An-da Shi, Li-ming Zhao, Li-Zhuang Shu, Shuo Lian, Zhang-di Yan, Shao-hui Huang, Guo-li Sheng, Yan Song, Yun-jia Liu, Fan Huan, Ming-hui Zhang, Zong-li Zhang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Biliary tract cancers (BTCs), including cholangiocarcinoma and gallbladder carcinoma, originate from the biliary epithelium and have a poor prognosis. Surgery is the only choice for cure in the early stage of disease. However, most patients are diagn
Externí odkaz:
https://doaj.org/article/2223e087bbcf4446aa7db24be56c49b0
Autor:
Long Jun Dai, Xu Zhi Ruan, Jue Wang, Yue Yuan, Zong Li Zhang, Yu Huang, Xue Peng Zhou, Zhong Ji Meng, Meng Ye Shan, Jun Ming Tang, Xing Rong Guo, Fu Yun Ji
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-3 (2020)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f2b5f8a9458c677547cb29daf0da862
https://doi.org/10.1038/s41392-020-0189-8
https://doi.org/10.1038/s41392-020-0189-8
Publikováno v:
Biomarkers in Medicine. 11:11-18
Aim: To investigate whether bile survivin and carbohydrate antigen 199 (CA199) can be helpful in distinguishing cholangiocarcinoma (malignant obstructive jaundice) from benign obstructive jaundice. Methods: Receiver operating characteristic curve was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2ab6787e4ac061ac65685983e5f129c
https://doi.org/10.2217/bmm-2016-0178
https://doi.org/10.2217/bmm-2016-0178
Publikováno v:
Surgery. 166:e3-e4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a10dd5d8801ebf89b030ce51fe5a165c
https://doi.org/10.1016/j.surg.2019.04.006
https://doi.org/10.1016/j.surg.2019.04.006
Publikováno v:
IUBMB Life. 67:191-201
Chemoresistance of colon cancer cells to the chemotherapeutics is still a main obstacle in treatment of this malignancy. The microRNA (miRNA) mediated chemosensitivity regulation in colon cancer cells is still largely unknown. Here we constructed a f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d207aff3dd83e972d54954325917ebd
https://doi.org/10.1002/iub.1361
https://doi.org/10.1002/iub.1361